Patient experiences with intrathecal baclofen as a treatment for spasticity – a pilot study

References

• Stevenson VL. Rehabilitation in practice: spasticity management. Clin Rehabil 2010;24:293–304
   PubMed Web of Science ®Google Scholar
• Sheean G, McGuire JR. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PM R 2009;1:827–33
   PubMedGoogle Scholar
• Pandyan AD, Gregoric M, Barnes MP, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil 2005;27:2–6
   PubMed Web of Science ®Google Scholar
• Graham LA. Management of spasticity revisited. Age Ageing 2013;42:435–41
   PubMed Web of Science ®Google Scholar
• Brennan PM, Whittle IR. Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Br J Neurosurg 2008;22:508–19
   PubMed Web of Science ®Google Scholar
• Stetkarova I, Yablon SA, Kofler M, Stokic DS. Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair 2010;24:609–19
   PubMed Web of Science ®Google Scholar
• Draulans N, Vermeersch K, Degraeuwe B, et al. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution. Clin Rehabil 2013;27:1137–43
   PubMed Web of Science ®Google Scholar
• Francisco GE, Saulino MF, Yablon SA, Turner M. Intrathecal baclofen therapy: an update. PM R 2009;1:852–8
   PubMedGoogle Scholar
• Natale M, Mirone G, Rotondo M, Moraci A. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives. Clin Neurol Neurosurg 2012;114:321–5
   PubMed Web of Science ®Google Scholar
• Posteraro F, Calandriello B, Galli R, et al. Timing of intrathecal baclofen therapy in persons with acquired brain injury: influence on outcome. Brain Inj 2013;27:1671–5
   PubMed Web of Science ®Google Scholar
• Rekand T, Gronning M. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up. J Rehabil Med 2011;43:511–14
   PubMed Web of Science ®Google Scholar
• Boviatsis EJ, Kouyialis AT, Korfias S, Sakas DE. Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 2005;107:289–95
   PubMed Web of Science ®Google Scholar
• Plassat R, Perrouin Verbe B, Menei P, et al. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004;42:686–93
   PubMed Web of Science ®Google Scholar
• Krach LE, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by programmable pump. Pediatr Rehabil 2006;9:210–18
   PubMedGoogle Scholar
• Marthur SN, Chu SK, McCormick Z, et al. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment PM R 2014;6:506--13
   Google Scholar
• Bowling A, Rowe G, Lambert N, et al. The measurement of patients' expectations for health care: a review and psychometric testing of a measure of patients' expectations. Health Technol Assess 2012;16:i–xii
   PubMed Web of Science ®Google Scholar
• Mahoney JS, Engebretson JC, Cook KF, et al. Spasticity experience domains in persons with spinal cord injury. Arch Phys Med Rehabil 2007;88:287–94
   PubMed Web of Science ®Google Scholar
• Krueger RA, Casey MA. Focus Groups – a practical guide for applied research. 3rd ed. Thousand Oaks: Sage Publications Inc.; 2000
   Google Scholar
• Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15:1277–88
   PubMed Web of Science ®Google Scholar
• Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004;24:105–12
   PubMed Web of Science ®Google Scholar
• Francisco GE, Hu MM, Boake C, Ivanhoe CB. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj 2005;19:359–64
   PubMed Web of Science ®Google Scholar
• Ivarsson B, Larsson S, Lührs C, Sjöberg T. Patients perceptions of information about risks at cardiac surgery. Patient Educ Couns 2007;67:32–8
   PubMed Web of Science ®Google Scholar
• Bhimani R. Intrathecal Baclofen therapy in adults and guideline for clinical nursing care. Rehabil Nurs 2008;33:110–16
   PubMed Web of Science ®Google Scholar
• Dalton CM, Keenan E, Jarrett L, et al. The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis. Mult Scler 2008;14:571–2
   PubMed Web of Science ®Google Scholar
• Roberts AG, Graves CR, Konrad PE, Groomes TE, Pfister AA, Damian MM, Charles PD. Intrathecal baclofen pump implantation during pregnancy. Neurology 2003;61:1156–7
   PubMed Web of Science ®Google Scholar
• Delhaas EM, Verhagen J. Pregnancy in a quadriplegic patient treated with continuous intrathecal baclofen infusion to manage her severe spasticity. A case report. Paraplegia 1992;309:527–8
   Google Scholar
• Heetla HW, Staal MJ, Kliphuis C, van Laar T. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord 2009;47:751–6
   PubMed Web of Science ®Google Scholar
• Nielsen JF, Hansen HJ, Sunde N, Christensen JJ. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clin Neurol Neurosurg 2002;104:42–145
   Web of Science ®Google Scholar
• Wetherington JP, Lambert NA. GABA(B) receptor activation desensitizes postsynaptic GABA(B) and A(1) adenosine responses in rat hippocampal neurones. J Physiol 2002;544:459–67
   PubMed Web of Science ®Google Scholar
• Heetla HW, Staal MJ, van Laar T. Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion. Spinal Cord 2010;48:483–6
   PubMed Web of Science ®Google Scholar
• Erwin A, Gudesblatt M, Bethoux F, et al. Intrathecal baclofen in multiple sclerosis: too little, too late? Mult Scler 2011;17:623–9
   PubMed Web of Science ®Google Scholar